A 16S rDNA amplicon library preparation method for gut microbiota detection in gestational diabetes mellitus

By constructing amplicon libraries through equal mixing of amplification products and ligation with PCR-free adapters, the problems of heterogeneous sequencing data and high cost in existing technologies are solved, achieving both accuracy and cost-effectiveness in detecting gut microbiota in gestational diabetes mellitus.

CN123063499APending Publication Date: 2026-11-10CARESPER MEDICAL TECH (CHANGZHOU) CO LTD
View PDF 0 Cites -1 Cited by

Patent Information

Application Number
CN202510578677.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-05-07
Publication Date
2026-11-10

Smart Images

  • Figure FT_1
    Figure FT_1
  • Figure FT_2
    Figure FT_2
  • Figure FT_3
    Figure FT_3
Patent Text Reader

Abstract

The application provides an amplicon library and a construction method thereof, mainly used for detecting the distribution characteristics of intestinal flora of pregnant women, and the method comprises the following steps: performing PCR amplification on the target fragments of multiple samples of the intestinal fecal samples of pregnant women to obtain multiple amplification products; then, the multiple amplification products are mixed in equal amounts to obtain a mixed product; the mixed product is sequentially subjected to fragmentation, end repair and 3' end A addition to obtain an A-containing repair product; and the A-containing repair product is connected with a linker by using PCR-free linker connection to obtain the amplicon library. By mixing the amplification products in equal amounts and using optimized PCR-free linker connection, the method avoids the preference generated by PCR and the chimeras in the environmental samples, makes the sequencing data uniform among different samples, makes the subsequent clustering analysis and technical repeatability more reasonable and accurate, and can more truly reflect the intestinal flora species abundance distribution of pregnant women with gestational diabetes mellitus, so that rapid detection results can be provided for patients with gestational diabetes mellitus.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of gut microbiota detection, specifically relating to a method for constructing a 16S rDNA amplicon library for gut microbiota detection in gestational diabetes mellitus. Background Technology

[0002] There are currently three main methods for library construction of 16S V3-V4 region amplicon samples for the illumina sequencing platform.

[0003] The first method is the older and more widely used PCR amplification library construction method, which includes a PCR amplification step in the library construction process. This method primarily employs two approaches for purifying and quantifying the PCR amplification products carrying the tag sequence. The first method involves purifying the PCR product using a PCR product recovery kit after PCR amplification, quantifying it using a spectrophotometer, and then mixing the samples in equimolar amounts. This purification and quantification homogenization method cannot remove primer dimers from the PCR product, affecting the accurate quantification of the target fragment by the spectrophotometer. It also prevents truly equimolar mixing between samples, resulting in poor homogeneity of sequencing data, a higher proportion of additional samples, and difficulty in ensuring project timelines. The second method involves separately excising and recovering the PCR product from the gel after PCR amplification, quantifying it using Qubit, and then mixing the samples in equimolar amounts. This purification and quantification homogenization method has lower gel recovery efficiency, leading to greater PCR product loss. This makes it difficult to ensure the initial library construction amount is within the normal range, thus affecting the success rate. Furthermore, this method is cumbersome and has higher reagent costs. Furthermore, when constructing libraries such as 16S rDNA or ITS using the aforementioned PCR amplification library construction method, errors can easily occur during the amplification of total genomic DNA (TDNA) due to the use of mixed templates with high sequence similarity. This can lead to the generation of "16S rDNA" sequences that are not normally present in the environment, significantly impacting library construction and potentially causing an overestimation of microbial diversity. Information analysis indicates that this library construction method results in unreasonable biological clustering among samples (library convergence) and poor technical reproducibility for the same sample.

[0004] The second method is the one-step amplification method, which completes the library construction process in a single PCR step. When using this method to construct the library for the above samples, the reagents compatible with Illumina MiSeq cannot be used for sequencing. Custom sequencing primers are required. Specifically, separately synthesized primers are used for sequencing the upstream conserved sequence of the 16S V3-V4 region as the P5 end, the downstream conserved sequence of the 16S V3-V4 region as the P7 end, and the reverse sequence of the downstream conserved sequence of the 16S V3-V4 region as the index. A specially prepared Phix library also needs to be synthesized. During sequencing, it can only be run in the same lane as amplicons with the same variable region. This not only affects the flexibility of sequencing scheduling but also compromises sequencing quality.

[0005] The third method is the Truseq PCR-free library preparation method, which involves constructing the library entirely using the Truseq PCR-free kit. This method allows for direct sequencing using reagents compatible with Illumina Miseq, and results in reasonable biological clustering between samples and good reproducibility within the same sample. However, the reagent cost is relatively high (TruSeq DNA PCR-Free Sample Preparation Kit), and its technical limitations need to be overcome.

[0006] Therefore, how to provide a simple, low-cost method for constructing amplicon libraries that yields good uniformity of sequencing data among different samples has become an urgent technical problem to be solved. Summary of the Invention

[0007] This invention provides an amplicon library and its construction method. It is mainly used to detect the distribution characteristics of the gut microbiota in pregnant women. Multiple samples of fecal samples from the pregnant woman's intestines are subjected to PCR amplification of the target fragment to obtain multiple amplification products. These multiple amplification products are then mixed in equal volumes to obtain a mixed product. The mixed product is then sequentially fragmented, end-repaired, and has an "A" added to its 3' end to obtain an "A"-repaired product. Finally, a PCR-free adapter is used to ligate the "A"-repaired product to obtain the amplicon library.

[0008] By mixing amplification products in equal volumes and using optimized PCR-free adapter ligation, this method avoids the biases generated by PCR and chimeras in environmental samples, resulting in good uniformity of sequencing data among different samples. This makes subsequent cluster analysis and technical reproducibility more reasonable and accurate, and can more realistically reflect the abundance distribution of gut microbiota species in pregnant women with gestational diabetes, providing rapid detection results for patients with gestational diabetes. Attached Figure Description

[0009] Figure 1 shows a schematic flowchart of amplicon library construction according to a typical embodiment of the present invention.

[0010] Figure 2 shows an electrophoretic detection diagram of the amplification products after PCR amplification in a typical embodiment of the present invention.

[0011] Figure 3 shows the results of library checking of the constructed amplicon library according to a typical embodiment of the present invention.

[0012] Figure 4 shows a structural diagram of the constructed amplicon library according to a typical embodiment of the present invention.

[0013] Figure 5 shows the species effect diagram of the data obtained from the amplicon library constructed using the method of the present invention. Specific implementation methods

[0014] To achieve the above objectives, the present invention adopts the following technical solution.

[0015] 1) Place approximately 300 mg of fecal sample into a 2 ml centrifuge tube, add 1 ml of PBS (0.1 mol / L pH 7.4) and 20 μL of 20% PVPP, and shake thoroughly to mix.

[0016] 2) Centrifuge at 2000 r / min for 6 min at room temperature, take the supernatant, add 1 ml of PBS to the precipitate, mix well, centrifuge, and take the supernatant.

[0017] 3) Combine the supernatants from both tests, centrifuge at 12000 r / min for 6 min, and collect the precipitate.

[0018] 1) Add 300 μL of lysis buffer 1 (0.15 mol / L NaCl, 0.1 mol / L Na2EDTA, pH 8.0), 100 mg / ml of lysozyme, 100 μL of proteinase K (10 mg / ml) to the pretreated sample in sequence, and shake at 37°C and 500 r / min for 30 min.

[0019] 2) Add 300 μL of lysis buffer 2 (10% SDS, 0.1 mol / L NaCl, 0.5 mol / L Tris-HCl, pH 8.0) and 50 μL of 20% PVPP, incubate at 65°C for 10 min, add 750 μL of Tris-saturated phenol:chloroform:isoamyl alcohol (25:24:1), mix and shake for 2 min, and centrifuge at 13000 r / min for 8 min.

[0020] 3) Transfer the supernatant from step 2.2 to another 2ml centrifuge tube: add an equal volume of Tris-saturated phenol: chloroform: isoamyl alcohol (25:24:1), mix and shake for 2min, then centrifuge at 13000r / min for 8min.

[0021] 4) Transfer the supernatant to another 2ml centrifuge tube: add 1 / 10 volume of 3mol / L sodium acetate and 2 volumes of anhydrous ethanol, precipitate at -20°C for 2 hours: centrifuge at 13000r / min for 15 minutes.

[0022] 5) Wash the precipitate once with 70% ice-cold ethanol and let it air dry naturally.

[0023] 6) Finally, dissolve in 50 μL of deionized water and store at -20°C.

[0024] 1) The concentration of DNA extracted in step 1.1 was detected using Qubit3.0.

[0025] 2) Take 1 μL of extracted DNA and use NanoDrop200 to detect DNA concentration and absorbance; select DNA with a concentration greater than 10 ng / ul and OD260 / 280 = 1.8-2.0 for subsequent library construction.

[0026] 4) Take 2 μL of the extracted DNA and check the DNA integrity using 1% agarose gel electrophoresis.

[0027] 4.1 Amplification of 16S rDNA V3-V4.

[0028] 1) Mix the sample and centrifuge.

[0029] Configuration system.

[0030] This step uses a one-step amplification method, with the forward primer being 341F: ACTCCTACGGGAGGCAGCAG and the reverse primer being 806R: GGACTACHVGGGTWTCTAAT.

[0031] Mix the sample thoroughly, centrifuge briefly, and run a gel electrophoresis to observe the fragment length of the library (Figure 2). A schematic diagram of the library structure is shown in Figure 3.

[0032] The PCR program settings are as follows.

[0033] 1) After the magnetic beads have equilibrated to room temperature, vortex the VAHTS DNA Clean Beads to mix them. Add 50 μl of VAHTS DNA Clean Beads to the above cDNA amplification reaction system and mix with a pipette more than 10 times to ensure that the whole system is homogeneous.

[0034] 2) Incubate at room temperature for 8 min to allow cDNA to bind to the magnetic beads. Place the reaction tube on a magnetic rack to separate the magnetic beads and liquid. After the solution becomes clear (about 5 min), carefully aspirate the supernatant and add 27 μl of VAHTS DNA Clean Beads. Mix thoroughly with a pipette at least 10 times to ensure the entire system is homogeneous. Incubate at room temperature for 8 min to allow cDNA to bind to the magnetic beads.

[0035] 3) Place the reaction tube on a magnetic rack to separate the magnetic beads and liquid. After the solution becomes clear (about 5 min), aspirate 67 μl of the supernatant and add 40 μl of VAHTS DNA Clean Beads. Mix thoroughly with a pipette at least 10 times to ensure the entire system is homogeneous. Incubate at room temperature for 8 min to allow cDNA to bind to the magnetic beads.

[0036] 4) Place the reaction tube on a magnetic rack to separate the magnetic beads and liquid. After the solution becomes clear (about 5 min), remove the supernatant. Keep the PCR tube on the magnetic rack at all times. Add 200 μl of freshly prepared 80% ethanol and incubate at room temperature for 30 sec. Carefully remove the supernatant.

[0037] 5) Repeat step 4 for a total of two rinses.

[0038] 6) Keep the PCR tubes in the magnetic rack at all times, and open the caps to air dry the magnetic beads for 5-10 minutes until there is no ethanol residue.

[0039] 7) After the magnetic beads have dried, remove the PCR tube from the magnetic rack, add 17 μl of Elution Buffer to cover the magnetic beads, and mix them thoroughly using a pipette. Incubate at room temperature for 2 min. If the magnetic beads dry and crack, extend the incubation time appropriately.

[0040] 8) After briefly centrifuging the PCR tubes, place them in a magnetic rack to separate the magnetic beads and liquid until the solution is clear (about 5 minutes).

[0041] 9) Carefully aspirate 15 μl of the supernatant and transfer it to a new low-adsorption EP tube. Store at -80°C.

[0042] 1) The library detection results using a 4μl sample are shown in Figure 4.

[0043] 7. Sequencing.

[0044] Paired-end 300bp sequencing was performed on the Illumina Miseq platform.

[0045] 8. Data Analysis.

[0046] 1) The raw reads obtained from sequencing are spliced ​​together, and the barcode and primer are removed to obtain raw tags.

[0047] 2) Filter according to base quality to obtain clean tags.

[0048] 3) Finally, the usearch61 method is used to refer to the gold database to remove chimeras and obtain effective tags.

[0049] 4) Perform database comparison and clustering on effective tags to generate OTUs (Operational Taxonomic Units).

[0050] 5) Use the generated OTUs for species classification and statistics to obtain the abundance information of the samples. Figure 5 shows the species distribution of gut microbiota in different gestational diabetes patients.

Claims

1. A method for constructing a 16S rDNA amplicon library for detecting gut microbiota in gestational diabetes mellitus, characterized in that... Includes the following steps: Step A: Sample Pretreatment: A-1 Add 300 mg of fecal sample to a centrifuge tube containing 1 ml PBS buffer and 20 μl 20% PVPP and vortex to mix; A-2 Centrifuge at 2000 rpm for 6 min and collect the supernatant. Repeat the extraction and combine the supernatants; A-3 Centrifuge at 2000 rpm for 6 min and collect the precipitate; Step B: DNA Extraction: B-1 Add lysis buffer 1 (0.15 mol / L NaCl, 0.1 mol / L Na2EDTA, pH 8.0), lysozyme, and proteinase K to the precipitate and vortex at 37°C; B-2 Add lysis buffer 2 (10% SDS, 0.1 mol / L NaCl, 0.5 mol / L Tris-HCl, pH 8.0) and PVPP, treat at 65°C, and then perform phenol-chloroform extraction; B-3 Repeat the extraction, precipitate with ethanol, wash with ice-cold ethanol and dissolve; Step C: Quality Control Testing: C-1 DNA concentration and purity were detected using Qubit 3.0 and NanoDrop 200; integrity was verified by 1% agarose gel electrophoresis at C-2; Step D: V3-V4 region amplification: primers 341F (ACTCCTACGGGAGGCAGCAG) and 806R (GGACTACHVGGGTWTCTAAT) were used. The PCR system included Prime STAR GXL enzyme, and the cycling parameters were: 95℃ pre-denaturation for 3 min, 35 amplification cycles (95℃ 45s, 51℃ 45s, 72℃ 45s), and final extension at 72℃ for 10 min; Step E: Library purification: three gradient magnetic bead purification was performed using VAHTS DNA Clean Beads, and finally eluted with Elution Buffer; Step F: Library quality control: quantification was performed using Qubit (concentration ≥5ng / μl), Q-PCR was used to detect molar concentration (≥5nmol / L), and fragment analysis (main peak 610bp); Step G: Illumina platform paired-end 300bp sequencing; Step H: Data analysis includes sequence assembly, quality control filtering, chimera removal, OTU clustering, and species annotation analysis.

2. The method according to claim 1, characterized in that... The lysis buffer 1 contains 100 mg / ml lysozyme and 5 μl 10 mg / ml proteinase K.

3. The method according to claim 1, characterized in that... The phenol-chloroform extraction was performed using a Tris-saturated phenol:chloroform:isoamyl alcohol (25:24:1) system, followed by precipitation with sodium acetate / ethanol after two extractions.

4. The method according to claim 1, characterized in that... The PCR amplification system contains: 2 μl DNA template, 1 μl P5 / P7 primers, 10 μl 5×PS GXL Buffer, 1 μl Prime STAR GXL enzyme, and 4 μl dNTP MIX.

5. The method according to claim 1, characterized in that... The magnetic bead purification process includes a three-step gradient binding: first, 50 μl of magnetic beads adsorbs impurities; second, 27 μl of magnetic beads enriches the target fragment; and third, 40 μl of magnetic beads purifies the target fragment.

6. The method according to claim 1, characterized in that... Data analysis employed the usearch61 algorithm to remove chimeras and performed OTU clustering analysis based on the Gold database.

7. The method according to claim 1, characterized in that... Final library quality requirements: OD260 / 280 = 1.8-2.0, concentration ≥ 10 ng / μl, effective concentration for Q-PCR detection ≥ 5 nmol / L.

8. The method according to claim 1, characterized in that... After processing, the sequencing data were used to obtain the composition and abundance profiles of the gut microbiota in patients with gestational diabetes mellitus.